Why Indian Drug Makers Challenge Global Patents
Explore the high-stakes legal battles between Indian generic manufacturers and global pharma giants. Understand the impact on drug prices, accessibility, and the evolving IP landscape in India.
Category : Search result: Ajanta Pharma
Natco Files to Revoke Novo Nordisk's Wegovy Patent in India
Hyderabad's Natco Pharma petitions Delhi High Court to revoke Novo Nordisk's semaglutide patent. The legal battle shapes India's future weight-loss drug market as 2026 patent expiry nears. Read more.
India Plans New Pharma Licence for Bulk Drugs to Boost Safety
India plans a major pharma licensing overhaul with a separate wholesale licence for bulk drugs and APIs to improve traceability and safety. This move follows global scrutiny over contaminated cough syrups and aims to regulate a $50-billion market.
Karnal Pharma Park Delays Leave Drug Makers in Limbo
Pharmaceutical manufacturers in Haryana await land allocation for the Karnal Pharma Park, a project delayed since 2021. The park promises to boost drug production and exports. Read about the industry's demands and government's plans.
Hindustan Laboratories Files DRHP for IPO with SEBI
Hindustan Laboratories has filed its Draft Red Herring Prospectus with SEBI for a proposed IPO. The issue comprises a fresh issue and an offer for sale. Discover key details about the pharma company's B2G business model and fund utilisation.
German Envoy in Awe of India's Art Treasures
German Ambassador Dr Philipp Ackermann, an art historian, shares his deep admiration for India's art, from Ajanta frescoes to Chola bronzes, and discusses how art can strengthen diplomacy. Discover his favorite museums and insights.
Fire at SVS Chemical Industries in Anakapalle, No Casualties
A major fire broke out at SVS Chemical Industries' pharma unit near Visakhapatnam. All 14 workers evacuated safely. Home Minister orders inquiry to prevent future incidents. Read the full report.
Indian Pharma Firms Eye Licensing Deals for Obesity Drugs
As patents expire, Indian drugmakers like Lupin and Ajanta Pharma are forging licensing and distribution deals for GLP-1 obesity drugs. The market is set for explosive growth. Explore the key partnerships and market dynamics.
Aurobindo Pharma buys Khandelwal Labs unit for ₹325 cr
Aurobindo Pharma strengthens its domestic formulations market with a ₹325 crore acquisition of Khandelwal Laboratories' non-oncology business. The deal includes 23 established brands and boosts presence in pain & anti-infective segments. Read more.
Tanya Mittal denies 150 bodyguards claim, shows factory
Bigg Boss 19's Tanya Mittal clarifies she never claimed 150 bodyguards, gives a tour of her pharma factory, and reveals an acting offer from Ekta Kapoor. Read her full statement.
Ayurveda Meets Western Medicine for Breast Cancer Care
Discover how Ayurveda is bridging the gap in breast cancer care, complementing Western treatments to manage side effects and improve patient quality of life. Learn about the integrated approach.
US Markets Close 2025 Higher Despite Final Session Loss
Wall Street's major indexes fell slightly on the last trading day of 2025 but are set for strong double-digit yearly gains, fueled by AI stocks. Nike and Vanda Pharma saw notable moves.
UHSR Rohtak Declares 2025 Exam Results: Download PDFs
Pandit Bhagwat Dayal Sharma University of Health Sciences, Rohtak has published results for B.Pharmacy, GNM, and M.Pharma exams. Download official gazettes from uhsr.ac.in.
INSV Kaundinya: Navy's Ancient Ship Recreated from Ajanta Art
The Indian Navy launches INSV Kaundinya, a sailing vessel recreated from a 5th-century painting in the Ajanta Caves. Discover this blend of ancient heritage and modern maritime prowess.
Indian Navy's INSV Kaundinya Inspired by Ajanta Cave Painting
The Indian Navy launches INSV Kaundinya, a unique sailing vessel meticulously recreated from a 5th-century painting in the Ajanta Caves. Discover this fusion of ancient maritime heritage and modern naval training.
6 Arrested in Varanasi Codeine Cough Syrup Racket
Varanasi and Mirzapur police crack down on a major codeine-based cough syrup smuggling ring, arresting six. The network used shell firms and hawala to supply syrup to Bangladesh at 10x price.
Sigachi MD Arrested Over Hyderabad Pharma Blast
Telangana police arrest Sigachi MD Amit Raj Sinha for negligence in June 30 blast that killed 54 workers. Case highlights safety failures in hazardous units. Read the full investigation details.
Govt Mulls 1-Year Extension for Pharma GMP Norms
The Indian government considers a one-year extension for MSMEs to comply with revised Schedule M GMP norms, aiming to prevent plant closures and safeguard its $50 billion pharma sector. Read more.
Ajanta Pharma's Semaglutide Deal Boosts Growth Prospects
Ajanta Pharma partners with Biocon to market weight-loss drug semaglutide in 26 markets. Deal expected to add ₹200 crore sales by FY28, enhancing its branded generics focus. Read more.
Obesity Drug Market in India Grows 10-Fold in 5 Years
India's anti-obesity market, now valued at over Rs 1,000 crore, is poised for explosive growth with new drugs and generics. Discover how AI and GLP-1 therapies are transforming healthcare.
Orange Biotech PCD Pharma Franchise: Lucrative Business Opportunity
Orange Biotech Private Limited unveils a nationwide PCD pharma franchise with high-profit margins, monopoly rights, and extensive product portfolio for entrepreneurs. Start your own pharma business today!
Aurobindo Pharma increases stake in China JV to 50%
Aurobindo Pharma's Dutch arm buys 20% more in China's Luoxin Aurovitas for $5M, aiming for 100% ownership by 2029 to scale up inhalation product manufacturing. Read the full strategic move.
Ajanta Pharma & Biocon Partner for Generic Weight Loss Drug
Ajanta Pharma partners with Biocon to distribute generic semaglutide in 26 Asian and African markets. The move targets the booming GLP-1 market post-patent expiry, leveraging Ajanta's strong distribution network.
JioHotstar Series Questions India's Pharmaceutical System
JioHotstar's new series 'Pharma' ignites public debate on drug pricing, ethics, and accessibility in India's healthcare system. Read the full analysis.
India Pharma Targets $500B, Innovation Hub by 2047
India's pharmaceutical industry gears up for a critical 5-year phase from 2026, aiming to become a $500 billion innovation hub by 2047. Learn how it plans to tackle challenges and seize opportunities.
UST & IIT Madras Partner to Nurture Deep-Tech Healthcare Startups
UST and IIT Madras Incubation Cell sign MoU to accelerate healthcare startups. 'Pitch to Win: Pharma 4.0' challenge sees 90+ entries. Winners get funding up to Rs 45 lakh. Read more.
Sonipat Trader Held in Rs 118 Cr GST Evasion Case
CGST Rohtak arrests Sonipat pharma trader Pawel Garg for alleged GST evasion of Rs 21.30 crore on sales of Rs 118.49 crore. Raid uncovers unaccounted transactions. Read the full details.
Rajit Kapur's Malayalam comeback after 25 years
National Award-winning actor Rajit Kapur discusses his return to Malayalam cinema with the medical drama 'Pharma', his role as Dr. Rajiv Rao, and the rise of South Indian OTT content.
Bangladesh Beats India to Export Weight-Loss Drugs to Emerging Markets
Bangladesh's pharma firms have a 2-year head start over Indian giants like Dr Reddy's in exporting generic semaglutide. Delhi HC allows exports, but domestic sales wait until 2026. Explore the competitive landscape.
Nivin Pauly's 'Pharma' Web Series Review: A Must-Watch Thriller
Nivin Pauly's 'Pharma', Malayalam's first medical drama web series, is now streaming. Our review explores its gripping plot, stellar cast, and why it's a binge-worthy thriller. Watch now!
Page 1 of 4